Design,synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors

Aminopeptidase N (APN/CD13) over expressed on tumour cells, plays a critical role in tumour invasion, metastasis and tumour angiogenesis. In this article, we described the design, synthesis and preliminary activity studies of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as APN inhibitors. The in vitro enzymatic inhibitions on APN from porcine kidney showed that compound 7e had the most potent inhibitory activity against APN with the IC₅₀ value to 1.26?±?0.01 μM, which is better than that of bestatin (IC₅₀?=?2.55?±?0.11 μM). In addition, compound 7e also showed better inhibitory activity against APN on human ovary clear cell carcinoma cell ES-2 than bestatin with the IC₅₀ value to 30.19?±?1.02 μM versus 60.61?±?0.1 μM. Compound 7e could be used as the lead compound in the future for anti-cancer agent research.     

Catalytic effect of (H2O)n (n = 1–3) clusters on the reaction of HNO2 + HO → H2O + NO2 under tropospheric conditions

ABSTRACT

The effect of (H₂O)_n (n?=?1–3) on the HNO₂?+?HO → H₂O?+?NO₂ reaction has been investigated theoretically at the CCSD(T)/CBS//B3LYP/6-311?+?G(3df,2pd) level of theory, coupled with rate constant calculations by using variational transition state theory. Our results show that, when (H₂O)_n (n?=?1–3) was introduced into HNO₂?+?HO → H₂O?+?NO₂ reaction, the product of the reaction did not change, but the potential energy surface became quite complex, yielding two kinds of reactions, namely HNO₂···(H₂O)_n (n?=?1–3)?+?HO and HO···(H₂O)_n (n?=?1–3)?+?HNO₂. In all catalysed reactions with (H₂O)_n (n?=?1–3), the former reaction type is favourable than the latter one with its effective rate constant respectively larger by 6–1 orders of magnitude than that of latter one. Within the temperature range of 240–320?K, the relative impacts on water monomer are much more obvious than dimer and trimer. However, the effective rate constant with water is larger by 658%–17% times of magnitude, showing that the positive water effect is obvious under atmospheric conditions.     

A Novel Highly Potent Autotaxin/ENPP2 Inhibitor Produces Prolonged Decreases in Plasma Lysophosphatidic Acid Formation In Vivo and Regulates Urethral Tension

Autotaxin, also known as ectonucleotide pyrophosphatase/phosphodiesterase 2 (ENPP2), is a secreted enzyme that has lysophospholipase D activity, which converts lysophosphatidylcholine to bioactive lysophosphatidic acid. Lysophosphatidic acid activates at least six G-protein coupled recpetors, which promote cell proliferation, survival, migration and muscle contraction. These physiological effects become dysfunctional in the pathology of cancer, fibrosis, and pain. To date, several autotaxin/ENPP2 inhibitors have been reported; however, none were able to completely and continuously inhibit autotaxin/ENPP2 in vivo. In this study, we report the discovery of a highly potent autotaxin/ENPP2 inhibitor, ONO-8430506, which decreased plasma lysophosphatidic acid formation.The IC₅₀ values of ONO-8540506 for lysophospholipase D activity were 6.4–19 nM for recombinant autotaxin/ENPP2 proteins and 4.7–11.6 nM for plasma from various animal species. Plasma lysophosphatidic acid formation during 1-h incubation was almost completely inhibited by the addition of >300 nM of the compound to human plasma. In addition, when administered orally to rats at a dose of 30 mg/kg, the compound demonstrated good pharmacokinetics in rats and persistently inhibited plasma lysophosphatidic acid formation even at 24 h after administration.Smooth muscle contraction is a known to be promoted by lysophosphatidic acid. In this study, we showed that dosing rats with ONO-8430506 decreased intraurethral pressure accompanied by urethral relaxation. These findings demonstrate the potential of this autotaxin/ENPP2 inhibitor for the treatment of various diseases caused by lysophosphatidic acid, including urethral obstructive disease such as benign prostatic hyperplasia.     

Synthesis,antitumor activity and molecular docking study of some novel 3-benzyl-4(3H)quinazolinone analogues

A novel series of 3-benzyl-substituted-4(3H)-quinazolinones were designed, synthesized and evaluated for their in vitro antitumor activity. The results of this study demonstrated that 2-(3-benzyl-6-methyl-4-oxo-3,4-dihydroquinazolin-2-ylthio)-N-(3,4,5-trimethoxyphenyl)acetamide, 2-(3-benzyl-6,7-dimethoxy-4-oxo-3,4-dihydroquinazolin-2-ylthio)-N-(3,4,5-trimethoxyphenyl)acetamide and 3-(3-benzyl-6-methyl-4-oxo-3,4-dihydroquinazolin-2-ylthio)-N-(3,4,5-trimethoxyphenyl)-propanamide have shown amazing broad spectrum antitumor activity with mean GI₅₀ (10.47, 7.24 and 14.12?µM. respectively), and are nearly 1.5–3.0-fold more potent compared with the positive control 5-FU with mean GI₅₀, 22.60?µM. On the other hand, compounds 6 and 10 yielded selective activities toward CNS, renal and breast cancer cell lines, whereas compound 9 showed selective activities towards leukemia cell lines. Molecular docking methodology was performed for compounds 7 and 8 into ATP binding site of EGFR-TK which showed similar binding mode to erlotinib, while compound 11 into ATP binding site of B-RAF kinase inhibited the growth of melanoma cell lines through inhibition of B-RAF kinase, similar to PLX4032.     

The pterin lumazine inhibits growth of methanogens and methane formation

The pterin compound lumazine [2, 4-(1H, 3H)-pteridinedione] inhibited the growth of several methanogenic archaea completely at a concentration of ≤ 0.6 mM and was bacteriocidal for Methanobacterium thermoautotrophicum strain Marburg. In contrast, growth of two non-methanogenic archaea, several eubacteria, and one eukaryote was not strongly affected at much higher concentrations. In washed-cell suspensions, methanogenesis from H₂ and CO₂ by Mb. thermoautotrophicum or from H₂ and methanol by Methanosarcina barkeri was inhibited by addition of lumazine. In cell-free extracts of Mb. thermoautotrophicum, H₂-driven methane production from CO₂ or CH₃-S-CoM was completely inhibited by 0.6 mM lumazine. The results suggest that the compound may be useful in probing the methanogenesis pathway or in selecting against methanogens. Received: 30 January 1996 / Accepted 15 May 1996     

Design,synthesis and biological evaluation of novel L-isoserine tripeptide derivatives as aminopeptidase N inhibitors

Aminopeptidase N (APN/CD13) is one of the essential proteins for tumour invasion, angiogenesis and metastasis as it is over-expressed on the surface of different tumour cells. Based on our previous work that L-isoserine dipeptide derivatives were potent APN inhibitors, we designed and synthesized L-isoserine tripeptide derivatives as APN inhibitors. Among these compounds, one compound 16l (IC₅₀?=?2.51?±?0.2 µM) showed similar inhibitory effect compared with control compound Bestatin (IC₅₀?=?6.25?±?0.4 µM) and it could be used as novel lead compound for the APN inhibitors development as anticancer agents in the future.     

Antioxidant activity of the chemical constituents from the flower buds of <Emphasis Type="Italic">Magnolia denudata</Emphasis>

The scavenging activity of the flower buds of Magnolia denudata Desrousseaux on reactive oxygen species (ROS) was evaluated using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) in HT 1080 cells. Methanol (MeOH) and dichloromethane (CH₂Cl₂) extracts inhibited dose-dependently generation of ROS in the cellular system. MeOH and CH₂Cl₂ extracts were combined and fractionated with n-hexane, 85% aqueous MeOH, and n-butanol (n-BuOH). Both n-hexane-soluble and 85% aqueous-soluble fractions showing strong radical-scavenging activity in the cellular system were further separated by diverse chromatographic methods to give five known lignans (1–5). All these compounds exhibited significant radical-scavenging effect on intracellular ROS in a dose-dependent manner. Their scavenging activity on various reactive oxygen species (ROS) was also evaluated using electron spin resonance (ESR) spin-trap techniques.     

Daily variation of oral malodour and related factors in community-dwelling elderly Thai

doi: 10.1111/j.1741‐2358.2011.00593.x Daily variation of oral malodour and related factors in community‐dwelling elderly Thai Objectives: The purposes of this study were (i) to estimate the prevalence of oral malodour, (ii) to evaluate the daily variation of oral malodour and (iii) to assess associations of volatile sulphur compound (VSC) concentrations with socio‐demographics, health behaviours and oral health status in community‐dwelling elderly Thai. Methods: The subjects were 428 dentate elderly people (67.6 ± 5.6 years) living in Phitsaulok, Thailand. Information on their socio‐demographics, general health and health behaviours was obtained by a questionnaire. Their dental condition, periodontal status and tongue coating were clinically examined. Their flow rates and the pH of unstimulated saliva were also assessed. Oral malodour was measured at four different times of day using an Oral Chroma?. Results: The proportions of subjects diagnosed with oral malodour using the thresholds of H₂S, CH₃SH and (CH₃)₂S were 60.5%, 62.9% and 80.7%, respectively. Concentrations of H₂S showed significant daily variation. Linear regression analysis demonstrated the following significant associations: (i) oral malodour from H₂S and thickness of the tongue coating, (ii) oral malodour from CH₃SH and periodontal pocket depth of 5 mm or more and the presence of gingival bleeding and (iii) oral malodour from (CH₃)₂S and systemic disease, medications and thickness of the tongue coating. Discussion: Oral malodour was shown to be prevalent among the elderly. Daily variation was observed in the concentration of H₂S. Tongue coating, periodontal disease, systemic diseases and medications were related to oral malodour. Therefore, these factors should be taken into consideration in oral malodour treatment and prevention programmes for the elderly.     

A Novel Cytotoxic Cerium Complex: Aquatrichloridobis(1,10‐phenanthroline)cerium(III) (KP776). Synthesis,Characterization, Behavior in H2O,Binding towards Biomolecules,and Antiproliferative Activity

The lanthanide complex aquatrichloridobis(1,10‐phenanthroline)cerium(III) [Ce(phen)₂(H₂O)Cl₃] (KP776) was fully characterized by elemental analysis, IR‐, and ¹H‐ and ¹³C‐NMR spectroscopy, as well as TG/DTA measurements, and its behavior in H₂O, important for the application as a chemotherapeutic, was studied. In addition, the binding of KP776 to nucleotides and single serum proteins was investigated by capillary electrophoresis, whereas binding to proteins in human plasma was observed by ICP‐MS. The compound shows promising anticancer properties in vitro: proliferation of human cancer cell lines is strongly inhibited with IC₅₀ values in the very low micromolar range.     

New κ-PNN′- and κ-PNN′O-polydentate ligands: Synthesis, coordination and structural studies

The three-step synthesis of new mixed P/N/N′/O-donor ligands C₆H₃(OH){2-NHC(O)CH₂NCHC₆H₄PPh₂}(4-CH₃) 3a·HH and C₆H₄(OH){3-NHC(O)CH₂NCHC₆H₄PPh₂} 3b·HH, by Schiff base condensation of the 1° amines C₆H₃(OH){2-NHC(O)CH₂NH₂}(4-CH₃) 2a or C₆H₄(OH){3-NHC(O)CH₂NH₂} 2b with C₆H₄(CHO)(2-PPh₂) in refluxing EtOH, is described. Reaction of 1 equiv. of 3a·HH or 3b·HH with MCl₂(cod) (M = Pt, Pd; cod = cycloocta-1,5-diene) affords the κ²-PN-chelate complexes MCl₂(3a·HH) (M = Pd 4a; M = Pt 4b) and MCl₂(3b·HH) (M = Pt 4c). The dichlorometal(II) complexes 4d and 4e, bearing instead a pendant 4-phenolic group, were similarly prepared (in >90% yield). Chloro-bridge cleavage of [Pd(μ-Cl)(η³-C₃H₅)]₂ with 3a·HH or 3b·HH gave the monocationic κ²-PN-chelate complexes [Pd(η³-C₃H₅)(3a·HH)]Cl 5a or [Pd(η³-C₃H₅)(3b·HH)]Cl 5b, respectively. Elimination of cod, and single CH₃ protonation, from Pt(CH₃)₂(cod) upon reaction with 1 equiv. of 3a·HH or 3b·HH in C₇H₈ at room temperature afforded the neutral complexes C₆H₃(OH){2-NC(O)CH₂NCHC₆H₄PPh₂Pt(CH₃)}(4-CH₃) 6a and C₆H₄(OH){3-NC(O)CH₂NCHC₆H₄PPh₂Pt(CH₃)} 6b, respectively bearing a monoanionic (3a·H⁻ or 3b·H⁻) κ³-PNN′-tridentate ligand. Amide and phenol deprotonation were readily achieved, using KO^tBu as base, to give high yields of the κ⁴-PNN′O-tetradentate complexes C₆H₃(O){2-NC(O)CH₂NCHC₆H₄PPh₂Pd}(4-CH₃) 7a and C₆H₃(O){2-NC(O)CH₂NCHC₆H₄PPh₂Pt}(4-CH₃) 7b bearing the dianionic ligand 3a²⁻. All new compounds have been characterised by multinuclear NMR, FTIR, mass spectroscopy and microanalysis. Single crystal X-ray studies have been performed on compounds 1b·1.5CH₂Cl₂, 3b·HH·0.5Et₂O, 6b·CHCl₃ and 7b·0.5Et₂O.     

Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice

Pramipexole, an agonist for dopamine (DA) D2/D3-receptors, has been used to treat both early and advanced Parkinson's disease (PD). In this study, we examined the effect of pramipexole on DA neurons in a PD model of C57BL/6 mice, which were treated with rotenone (30 mg/kg, p.o.) daily for 28 days. Pramipexole (1 mg/kg, i.p.) was injected daily 30 min before each oral administration of rotenone. Chronic oral administration of rotenone caused a loss of DA neurons in the substantia nigra pars compacta (SNpc), motor deficits and the up-regulation of α-synuclein immunoreactivity in some surviving DA neurons. Pramipexole inhibited rotenone-induced DA neuronal death and motor deficits, and reduced immunoreactivity for α-synuclein. In addition, pramipexole inhibited the in vitro oligomerization of human wild-type α-synuclein by H₂O₂ plus cytochrome c. To examine the neuroprotective effect of pramipexole against oxidative stress, we used a DJ-1-knockdown SH-SY5Y cell line and electron spin resonance (ESR) spectrometry. Simultaneous treatment with H₂O₂ and pramipexole resulted in the significant protection of DJ-1-knockdown cells against cell death in a concentration-dependent manner. A high concentration of pramipexole directly scavenged hydroxyl radical (OH) generated from H₂O₂ and Fe²⁺. Furthermore, pramipexole increased Bcl-2 immunoreactivity in DA neurons in the SNpc. These results suggest that pramipexole may protect DA neurons against exposure to rotenone by chronic oral administration, and this effect is mediated by multiple functions including scavenging of OH and induction of Bcl-2 protein.     

The reaction of [η:C5H4-(CH2)n-C6H5]2MCl2 complexes (n=1-5; M=Zr, Hf) with EtLi

The reaction of metallocene complexes of the type [η⁵:C₅H₄-(CH₂)_n-C₆H₅]₂MCl₂ (n=1-5; M=Zr, Hf) with EtLi gives the mono nuclear ethyl derivatives [η⁵:C₅H₄-(CH₂)_n-C₆H₅]₂M(Et)Cl and the metallacycles [η⁵:C₅H₄-(CH₂)_n-C₆H₅][η⁵:C₅H₄-(CH₂)_n-η¹:C₆H₄]MEt. A large excess of EtLi affords the dinuclear species [η⁵:C₅H₄-(CH₂)_n-η⁶:C₆H₅]₂M₂Cl₂ (n=2-5). All types of complexes can be activated with methylalumoxane (MAO) and then be used for catalytic polymerization of ethylene.     

Synthesis and antimicrobial activity of copper(II) and manganese(II) α,ω-dicarboxylate complexes

Copper(II) ,-dicarboxylate complexes of general formulae, [Cu(O₂C(CH₂)_nCO₂)]·xH₂O, [Cu(O₂C(CH₂)_nCO₂) (phen)₂]·xH₂O and [Cu(O₂C(CH₂)_nCO₂)(bipy)_y]·xH₂O (n=1–8; y=1, 2; phen = 1,10-phenanthroline; bipy = 2,2-bipyridine) were synthesised. These copper complexes, some related manganese(II) complexes and the metal-free ligands were screened in vitro for their ability to inhibit the growth of Candida albicans. Metal-free 1,10-phenanthroline and all of the copper(II) and manganese(II) phenanthroline complexes were potent growth inhibitors, with only one bipyridine complex, [Cu(O₂C(CH₂)CO₂)(bipy)₂]·2H₂O, having moderate activity. The remaining substances were effectively inactive. Complexes which were active against C. albicans also proved effective against C. glabrata, C. tropicalis and C. kreusi with the manganese complexes retaining superior activity. For the phenanthroline complexes the active drug species is thought to be the dication [M(phen)₂(H₂O)_n]²⁺ (M = Cu, Mn). Escherichia coli and Staphylococcus aureus were resistant to all of the metal complexes and also to metal-free 1,10-phenanthroline. Only the copper phenanthroline complexes showed intermediate activity against Pseudomonas aeruginosa.     

Structures and luminescent sensors of mixed‐counterions based salen‐type lanthanide coordination polymers

Reactions of N,N′‐bis (salicylidene)‐1,2‐cyclohexanediamine (H₂L) with mixed lanthanide counterions of LnCl₃·6H₂O and Ln (NO₃)₃·6H₂O afford six H₂L lanthanide coordination polymers, e.g. {[Pr(H₂L)₂(NO₃)₂Cl]·2CH₂Cl₂}_n ( 1 ); {[Ln(H₂L)_1.5(NO₃)₃]₂·5CHCl₃·mCH₃OH}_n [Ln = Sm ( 2 ), Eu ( 3 ), Gd ( 4 ), Tb ( 5 ) and Yb ( 6 ); m = 1 ( 2 – 5 ); m = 0 ( 6 )]. X‐ray crystallographic analysis reveals that complex 1 exhibits three‐dimensional diamondoid topologic structure and complexes 2 – 6 are of two‐dimensional structure. Luminescent spectra show that complexes 1 and 6 have characteristic near‐infrared (NIR) emission of praseodymium (III) and ytterbium (III) ions and complexes 2 – 5 emit luminescence in the visible region. Complexes 3 and 6 reveal sensitive luminescence responses to formaldehyde.     

Heterometallic coordination polymers constructed by linear ligands

Eight lanthanide–copper coordination polymers of linear rigid 4-(4-pyridyl)benzoate(L¹) and isonicotinate(L²), [LnCuI(L¹)₂(OAc) (H₂O)]_n (Ln = Pr, 1; Nd, 2; Sm, 3; Eu, 4; Gd, 5), [Ln₂Cu₄I₃(L²)₇ (H₂O)]_n (Ln = La, 6; Pr, 7), and [Nd₂Cu₇I₆(L²)₇ (H₂O)₆]_n·2.5nH₂O (8), were hydrothermally synthesized and structurally characterized by single-crystal X-ray diffraction. The three-dimensional frameworks of 1–5 can be described as wave-like layer modules of [Ln(L¹)₂(OAc)(H₂O)]_n linking with each other through dimeric units of Cu₂I₂, whereas that of compounds 6 and 7 are constructed by layer modules of and Cu₄I₃ clusters. As for 8, dimeric units of Nd₂(L²)₇(H₂O)₆ connect layered polymeric forming a 3D framework.     

Conformationally Restricted 2-Substituted Wyosine Derivatives. 1H, 13C,and 15N NMR Study

Abstract

It was found by ¹H, ¹³C and ¹⁵N NMR study that substitution of 4,9-dihydro-4, 6-dimethyl-9-oxo-3-(2′,3′,5′-tri-O-acetyl-β-D-ribofuranosyl) imidazo [1,2-a]purine (wyosine triacetate, 1) at C2 position with electronegative groups CH₃O and C₆H₅CH₂O results in a noticeable electron distribution disturbance in the “left-hand” imidazole ring and a significant increase in the North conformer population of the sugar moiety.     

Synthesis,antitumour activities and molecular docking of thiocarboxylic acid ester-based NSAID scaffolds: COX-2 inhibition and mechanistic studies

A new series of NSAID thioesters were synthesized and evaluated for their in vitro antitumor effects against a panel of four human tumor cell lines, namely: HepG2, MCF-7, HCT-116 and Caco-2, using the MTT assay. Compared to the reference drugs 5-FU, afatinib and celecoxib, compounds 2b, 3b, 6a, 7a, 7b and 8a showed potent broad-spectrum antitumor activity against the selected tumour cell lines. Accordingly, these compounds were selected for mechanistic studies about COX inhibition and kinase assays. In vitro COX-1/COX-2 enzyme inhibition assay results indicated that compounds 2b, 3b, 6a, 7a, 7b, 8a and 8?b selectively inhibited the COX-2 enzyme (IC₅₀?=?～0.20–0.69?μM), with SI values of (>72.5–250) compared with celecoxib (IC₅₀?=?0.16?μM, COX-2 SI:?>?312.5); however, all the tested compounds did not inhibit the COX-1 enzyme (IC₅₀?>?50?μM). On the other hand, EGFR, HER2, HER4 and cSrc kinase inhibition assays were evaluated at a 10?μM concentration. The selected candidates displayed limited activities against the various tested kinases; the compounds 2a, 3b, 6a, 7a, 7b and 8a showed no activity to weak activity (% inhibition?=?～0–10%). The molecular docking study revealed the importance of the thioester moiety for the interaction of the drugs with the amino acids in the active sites of COX-2. The aforementioned results indicated that thioester based on NSAID scaffolds derivatives may serve as new antitumor compounds.     

Complexes of the fac-{Re(CO)3} core with tridentate ligands derived from arylpiperazines

Arylpiperazines, XC₆H₄N(CH₂CH₂)₂NH, are readily alkylated to give the N-alkylpiperazines of the type XC₆H₄N(CH₂CH₂)₂N(CH₂)_nNH₂. The amine functions of these derivatives are in turn easily subjected to mono- or dialkylation to provide potentially tridentate ligands of the types XC₆H₄N(CH₂CH₂)₂N(CH₂)_nN(H)(CH₂Y) and XC₆H₄N(CH₂CH₂)₂N(CH₂)_nN(CH₂Y)(CH₂Z), respectively. The latter class of dialkylated derivatives may be symmetrically (Y=Z) or unsymmetrically (Y ≠ Z) substituted. The donor groups Y and Z of this study include pyridine, imidazole, methyl-imidazole, thiazole, carboxylate and thiolate.The reactions of these ligands with [NEt₄]₂[Re(CO)₃Br₃] yield complexes of the type [Re(CO)₃{(YCH₂)N(H)(CH₂)_n(H)_xN(CH₂CH₂)₂N(H)_yC₆H₄X}]ⁿ and [Re(CO)₃{(ZCH₂)(YCH₂)N(CH₂)_n(H)_xN(CH₂CH₂)₂N(H)_yC₆H₄X}]ⁿ where the molecular charge n (0, +1, or +2) depends on the nature of the donor groups Y and Z (whether neutral or anionic or a combination of neutral and anionic) and on the degree of protonation of the piperazine unit (x=0 or 1; y=0 or 1). This variety of tridentate chelators provides complexes with fac-{Re(CO)₃N₃}, {Re(CO)₃N₂O}, {Re(CO)₃NO₂}, {Re(CO)₃N₂S} and {Re(CO)₃NS₂} coordination geometries. The structures of the model compound [Re(CO)₃{(CH₃N₂C₃H₂CH₂)N(H)CH₂CH₂-piperidine}]Br · H₂O, [Re(CO)₃{(CH₃N₂C₃H₂CH₂)N(H)CH₂CH₂-Fphenpip}]Br, [Re(CO)₃{(NC₅H₄CH₂)N(H)CH₂CH₂-Fphenpip}]Br, [Re(CO)₃{(O₂CCH₂)₂NCH₂CH₂CH₂-CH₃OphenpipH}] · xCH₃OH (x≈0.875), [Re(CO)₃{(NC₅H₄CH₂)₂NCH₂CH₂CH₂-CH₃OphenpipH}]Br₂ · 2CH₂Cl₂ · H₂O and [Re(CO)₃{(CH₃N₂C₃H₂CH₂)(O₂CCH₂)NCH₂CH₂CH₂-CH₃OphenpipH₂}]BrCl · 1.5CH₃OH · H₂O are discussed (phenpip: phenylpiperazine, -C₆H₄N(CH₂CH₂)₂N-).     

Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents

A new series of functionalized amino acid derivatives N-substituted 1-N-(tert-butoxycarbonyl)-2,2-dimethyl-4-phenyl-5-oxazolidine carboxamide (1-17) and 1-N-substituted-3-amino-2-hydroxy-3-phenylpropane-1-carboxamide (18-34) were synthesized and evaluated for their in vitro cytotoxicity against human cancer cell lines. Compound 6 has shown interesting cytotoxicity (IC₅₀ = 5.67 μm) in ovarian cancer, while compound 10 exhibited promising cytotoxicity in ovarian (IC₅₀ = 6.1 μm) and oral (IC₅₀ = 4.17 μm) cancers. These compounds could be of use in designing new anti-cancer agents.     

Synthesis of cyclopentadienyl ruthenium(II) complexes containing tethered functionalities

The reaction of [C₅H₄(CH₂)_nX]Tl (1: n = 2, X = NMe₂, OMe, CN; n = 3, X = NMe₂) with [(η⁶-C₆H₆)RuCl(μ-Cl)]₂, 2, afforded the sandwich compounds [{η⁵-C₅H₄(CH₂)_nX}Ru(η⁶-C₆H₆)]PF₆, 3, and [η⁵-C₅H₄(CH₂)_nX]₂Ru, 4. Photolytic cleavage of 3 in acetonitrile afforded the tethered products [{η⁵:κN-C₅H₄(CH₂)_nX}Ru(CH₃CN)₂]PF₆, 5.